Compare Fukuda Denshi Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 0.54% CAGR growth in Net Sales over the last 5 years
2
Poor long term growth as Net Sales has grown by an annual rate of 0.54% over the last 5 years
3
Flat results in Jun 26
4
With ROE of 9.87%, it has a attractive valuation with a 2.35 Price to Book Value
5
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
JPY 433,716 Million (Mid Cap)
24.00
NA
0.00%
-0.34
10.07%
2.30
Revenue and Profits:
Net Sales:
30,985 Million
(Quarterly Results - Jun 2026)
Net Profit:
3,079 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.07%
0%
21.07%
6 Months
34.04%
0%
34.04%
1 Year
76.62%
0%
76.62%
2 Years
67.97%
0%
67.97%
3 Years
133.2%
0%
133.2%
4 Years
58.86%
0%
58.86%
5 Years
17.98%
0%
17.98%
Fukuda Denshi Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.54%
EBIT Growth (5y)
9.52%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.79
Tax Ratio
30.48%
Dividend Payout Ratio
33.66%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
23.87%
ROE (avg)
10.63%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
2.35
EV to EBIT
14.67
EV to EBITDA
10.05
EV to Capital Employed
3.04
EV to Sales
2.64
PEG Ratio
7.42
Dividend Yield
NA
ROCE (Latest)
20.73%
ROE (Latest)
9.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
30,985.00
30,376.00
2.00%
Operating Profit (PBDIT) excl Other Income
7,688.00
6,959.00
10.48%
Interest
16.00
14.00
14.29%
Exceptional Items
0.00
5.00
-100.00%
Consolidate Net Profit
3,079.00
2,829.00
8.84%
Operating Profit Margin (Excl OI)
148.20%
137.60%
1.06%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 2.00% vs 0.12% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 8.84% vs -6.66% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
139,697.00
139,007.00
0.50%
Operating Profit (PBDIT) excl Other Income
38,507.00
36,424.00
5.72%
Interest
57.00
50.00
14.00%
Exceptional Items
-309.00
231.00
-233.77%
Consolidate Net Profit
18,790.00
18,605.00
0.99%
Operating Profit Margin (Excl OI)
190.50%
186.10%
0.44%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 0.50% vs -0.94% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 0.99% vs -0.47% in Mar 2025
About Fukuda Denshi Co., Ltd. 
Fukuda Denshi Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






